BIT:GPI

Stock Analysis Report

Executive Summary

GPI SpA provides ICT healthcare solutions for various public and private sector in Italy and internationally.


Snowflake Analysis

Proven track record and fair value.

Share Price & News

How has GPI's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GPI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

22.9%

GPI

5.4%

IT Healthcare Services

6.3%

IT Market


1 Year Return

-26.0%

GPI

-16.6%

IT Healthcare Services

-24.2%

IT Market

Return vs Industry: GPI underperformed the Italian Healthcare Services industry which returned -16.6% over the past year.

Return vs Market: GPI underperformed the Italian Market which returned -24.2% over the past year.


Shareholder returns

GPIIndustryMarket
7 Day22.9%5.4%6.3%
30 Day-2.6%-17.5%-26.9%
90 Day-15.9%-23.0%-28.8%
1 Year-23.3%-26.0%-15.5%-16.6%-20.9%-24.2%
3 Year-28.1%-34.5%-8.6%-11.8%-13.3%-22.0%
5 Yearn/a34.8%25.6%-23.1%-49.3%

Price Volatility Vs. Market

How volatile is GPI's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is GPI undervalued compared to its fair value and its price relative to the market?

12.39x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: GPI (€6.76) is trading above our estimate of fair value (€5.79)

Significantly Below Fair Value: GPI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: GPI is good value based on its PE Ratio (12.4x) compared to the Healthcare Services industry average (36.1x).

PE vs Market: GPI is good value based on its PE Ratio (12.4x) compared to the Italian market (12.5x).


Price to Earnings Growth Ratio

PEG Ratio: GPI is poor value based on its PEG Ratio (2.6x)


Price to Book Ratio

PB vs Industry: GPI is good value based on its PB Ratio (1.7x) compared to the XE Healthcare Services industry average (3.2x).


Next Steps

Future Growth

How is GPI forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

4.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GPI's forecast earnings growth (4.8% per year) is above the savings rate (1.2%).

Earnings vs Market: GPI's earnings (4.8% per year) are forecast to grow slower than the Italian market (10.1% per year).

High Growth Earnings: GPI's earnings are forecast to grow, but not significantly.

Revenue vs Market: GPI's revenue (5% per year) is forecast to grow faster than the Italian market (1.8% per year).

High Growth Revenue: GPI's revenue (5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GPI's Return on Equity is forecast to be low in 3 years time (12.3%).


Next Steps

Past Performance

How has GPI performed over the past 5 years?

27.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GPI has high quality earnings.

Growing Profit Margin: GPI's current net profit margins (3.9%) are higher than last year (3.7%).


Past Earnings Growth Analysis

Earnings Trend: GPI's earnings have grown significantly by 27.4% per year over the past 5 years.

Accelerating Growth: GPI's earnings growth over the past year (22.2%) is below its 5-year average (27.4% per year).

Earnings vs Industry: GPI earnings growth over the past year (22.2%) exceeded the Healthcare Services industry -4.6%.


Return on Equity

High ROE: GPI's Return on Equity (13.9%) is considered low.


Next Steps

Financial Health

How is GPI's financial position?


Financial Position Analysis

Short Term Liabilities: GPI's short term assets (€178.2M) exceed its short term liabilities (€118.6M).

Long Term Liabilities: GPI's short term assets (€178.2M) exceed its long term liabilities (€117.2M).


Debt to Equity History and Analysis

Debt Level: GPI's debt to equity ratio (186.9%) is considered high.

Reducing Debt: GPI's debt to equity ratio has increased from 167.6% to 186.9% over the past 5 years.

Debt Coverage: GPI's debt is not well covered by operating cash flow (5%).

Interest Coverage: GPI's interest payments on its debt are well covered by EBIT (10.2x coverage).


Balance Sheet

Inventory Level: GPI has a low level of unsold assets or inventory.

Debt Coverage by Assets: GPI's debt is covered by short term assets (assets are 1.5x debt).


Next Steps

Dividend

What is GPI's current dividend yield, its reliability and sustainability?

4.88%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GPI's dividend (4.88%) is higher than the bottom 25% of dividend payers in the Italian market (2.53%).

High Dividend: GPI's dividend (4.88%) is low compared to the top 25% of dividend payers in the Italian market (5.9%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, GPI has been paying a dividend for less than 10 years.

Growing Dividend: GPI's dividend payments have increased, but the company has only paid a dividend for 3 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (60.5%), GPI's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GPI's dividends in 3 years are forecast to be well covered by earnings (15.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.9yrs

Average board tenure


CEO

Fausto Manzana (60yo)

no data

Tenure

€371,667

Compensation

Mr. Fausto Manzana serves as the Executive Chairman and Chief Executive Officer at GPI S.p.A. and Director Since January 4, 2013. 


CEO Compensation Analysis

Compensation vs Market: Fausto's total compensation ($USD412.09K) is about average for companies of similar size in the Italian market ($USD358.84K).

Compensation vs Earnings: Insufficient data to compare Fausto's compensation with company performance.


Board Members

NamePositionTenureCompensationOwnership
Fausto Manzana
Executive Chairman & CEOno data€371.67kno data
Andrea Mora
Executive Vice Chairmanno data€15.00kno data
Sergio Manzana
Executive Director7.17yrs€85.94kno data
Dario Manzana
Executive Director6.25yrs€44.20kno data
Antonio Perricone
Non-Executive Director3.25yrs€15.00kno data
Edda Delon
Lead Independent Directorno data€20.00kno data
Paolo De Santis
Non-Executive Independent Director2.42yrs€25.00kno data
Sergio Fedrizzi
Member of Statuary Auditor4.92yrsno datano data
Marco Salvatore
Member of Statuary Auditor3.25yrsno datano data
Stefano Placa
President of Statutory Auditor6.25yrsno datano data

4.9yrs

Average Tenure

54yo

Average Age

Experienced Board: GPI's board of directors are considered experienced (4.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

GPI SpA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: GPI SpA
  • Ticker: GPI
  • Exchange: BIT
  • Founded: 1988
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €106.780m
  • Shares outstanding: 15.80m
  • Website: https://www.gpi.it

Location

  • GPI SpA
  • Via Ragazzi del '99, 13
  • Trento
  • Trento
  • 38123
  • Italy

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GPIBIT (Borsa Italiana)YesCommon StockITEURDec 2016
GPIMBATS-CHIXE (BATS 'Chi-X Europe')YesCommon StockGBEURDec 2016

Biography

GPI SpA provides ICT healthcare solutions for various public and private sector in Italy and internationally. Its products and services portfolio includes information systems and hi-tech platform for healthcare services, automated warehouse system for hospital and pharmacies, telemedicine and virtual care, DTM services, and e-payment solutions. It develops an EHR platform for diagnosis and treatment; clinical collaboration platform that enables clinicians to share patient information, such as reports, images, and structured data; IT solution for the management of various processes of neonatal intensive care unit, such as medical treatment, assistance, and information exchange between medical staff and parents; and a modular hospital information system to manage various clinical activities in private and public hospitals. The company also offers solutions for automated drug storage and picking system; a virtual care solution for patients', doctors, and healthcare operators; and Phebo, a platform for H2T evaluation of biometrics observations for tele-monitoring, virtual care, and telemedicine activities. The company was founded in 1988 and is based in Trento, Italy. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/28 00:36
End of Day Share Price2020/03/27 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.